Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -227.17MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
Sector
Industry
History
$ 5.3Close
$ 1.34 - $ 5.92 52-Week Range
Ticker Information
Ticker
SANACompany Name
SANA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSANA BIOTECHNOLOGY INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SANA - EBITDA Historical data
| Date | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
|---|---|---|---|
| 6/30/2025 | $ 25.01M | $ -252.18M | $ -227.17M |
| 3/31/2025 | $ 25.87M | $ -208.67M | $ -182.8M |
| 12/31/2024 | $ 27.07M | $ -266.76M | $ -239.69M |
| 9/30/2024 | $ 33.7M | $ -305.81M | $ -272.11M |
| 6/30/2024 | $ 35.3M | $ -244.9M | $ -209.6M |
| 3/31/2024 | $ 37.21M | $ -308.61M | $ -271.4M |
| 12/31/2023 | $ 37.82M | $ -283.25M | $ -245.43M |
| 9/30/2023 | $ 30.77M | $ -275.58M | $ -244.81M |
| 6/30/2023 | $ 30.18M | $ -361.69M | $ -331.5M |
| 3/31/2023 | $ 29.21M | $ -320.15M | $ -290.94M |
Key Performance Insights, Last 5 Years
- SANA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) EBITDA stands at $ -134.4M.
- Over the past 5 years, SANA BIOTECHNOLOGY INC's average EBITDA has been $ -254.58M.
- The median EBITDA for SANA BIOTECHNOLOGY INC during this period was $ -258.42M
- SANA BIOTECHNOLOGY INC reached its highest EBITDA over the past 5 years at $ -134.4M.
- The lowest EBITDA recorded by SANA BIOTECHNOLOGY INC in the same timeframe $ -342.92M
Similar metrics to EBITDA:
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].EBIT + DepAmor
(=) EBITDA EBITDA for SANA BIOTECHNOLOGY INC is calculated as follows: EBIT [ $ -138.32M ] + DepAmor [ $ 3.92M ]
(=) EBITDA [ $ -134.4M ] SANA - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years
$ -342.92M
Minimum
Sep 30, 2021
$ -134.4M
Maximum
Dec 31, 2019
$ -254.58M
Average
$ -258.42M
Median
EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.8M with a standard deviation of $ 166.97M.
The following table provides additional summary stats:
EBITDA in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | $ -493.3M |
| max | $ 590.6M |
| average | $ 58.8M |
| median | $ 8.83M |
| std | $ 166.97M |